BiotechTube
Home/Inthera Bioscience/Kim Andersen, PhD
KA

Kim Andersen, PhD

Head of Drug Discovery

Inthera Bioscience

Therapeutic Areas

Oncology

Inthera Bioscience Pipeline

DrugIndicationPhase
INTH-454Advanced Prostate Cancer (CRPC) and Colorectal Cancer (CRC)IND-ready / Pre-clinical

Leadership Team at Inthera Bioscience

MK
Mark Krul
Chief Executive Officer
BH
Bernd Hentsch, PhD
Chief Development Officer
FH
Frank Hennecke, PhD
Head of CMC Development
CA
Catherine Ammann
Head HR & Administration
View full Inthera Bioscience profile